INCATE and Cystic Fibrosis Foundation Collaborate to Combat Antimicrobial Resistance

February 26, 2026— INCATE (INCubator for Antibacterial Therapies in Europe), the antimicrobial incubator supporting the advancement of early-stage anti-infective innovation, today announced a collaboration with the Cystic Fibrosis Foundation to advance research, innovation, and solutions addressing antimicrobial resistance (AMR). People living with cystic fibrosis (CF) are particularly vulnerable…